+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 7Years +
All Genders
ID07182981

Study of How Scleroderma Affects Chewing and Swallowing in Children and Adults Assessing Physical and Psychosocial Health in Patients with Scleroderma

Led by Hacettepe University · Updated on 2025-09-19

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are examining the physical function, chewing, and swallowing abilities of both children and adults diagnosed with scleroderma. The study aims to assess these individuals on a biopsychosocial level to better support disease management and identify effective scales for future research specific to chewing and swallowing performance in scleroderma. Participants diagnosed with scleroderma, including children aged 7 to 18 and adults over 18, will complete questionnaires designed to evaluate their biopsychosocial status along with their chewing and swallowing abilities. The study uses a range of assessment tools such as the Pediatric Eating Assessment Scale, Chewing and Swallowing Tests, and other specific scales focused on skin involvement, hand mobility, and quality of life. During the study, participants will complete various questionnaires and undergo evaluations over two weeks, including tests for mouth opening, swallowing challenges, and biopsychosocial assessments. Researchers will measure outcomes related to swallowing function, physical health, and psychological status to better understand the impact of scleroderma. The total participation involves these assessments without additional treatment interventions.

CONDITIONS

Brief Title

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Research Team

O

Orkun Tüfekçi, PT, PhD(c)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here